Chondrosarcoma in Dogs
Dear OncoLink "Ask the Experts,"
My dog, Kaya, was recently diagnosed with a chondrosarcoma in his left nasal cavity. The tumor extends from the middle of the nose to the ocular socket. There is no bone deterioration present. The oncologist recommended high dosage radiation followed by chemotherapy.
My question is regarding the 2 schools of thought about radiation. I have read that many hospitals believe that surgery followed by low dosage radiation is the most effective means of treatment. The others believe that high dosage radiation with no surgery is the most effective treatment. Is there a difference in results between the 2 treatments? If there is a difference is it significant enough to warrant me taking Kaya to a hospital that performs the most effective procedure?
Thank you for your site and for your time.
Lili Duda, VMD, Editor of the OncoLink Veterinary Oncology Section, responds:
The current consensus is that either surgery (rhinotomy) plus low-energy radiation therapy OR high-energy radiation therapy alone are roughly equivalent treatment options for canine nasal chondrosarcoma. However, low energy radiation therapy is rarely used anymore in veterinary medicine (due to lack of availability), so by default, high-energy radiation therapy alone is considered the treatment of choice. The limited published information available suggests that surgery combined with high-energy radiation (for canine nasal tumors) confers a worse prognosis than high-energy radiation alone. Systemic chemotherapy has not been shown to improve prognosis.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2016 Trustees of The University of Pennsylvania